Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 667,403
  • Shares Outstanding, K 80,410
  • Annual Sales, $ 244,080 K
  • Annual Income, $ -5,720 K
  • 36-Month Beta 0.84
  • Price/Sales 2.61
  • Price/Cash Flow 18.27
  • Price/Book 3.89

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.10 +3.33%
on 01/12/18
9.27 -9.76%
on 12/18/17
-0.81 (-8.82%)
since 12/15/17
3-Month
7.82 +7.03%
on 10/25/17
9.49 -11.80%
on 11/30/17
-1.15 (-12.03%)
since 10/16/17
52-Week
7.12 +17.56%
on 05/18/17
11.63 -28.03%
on 09/11/17
-0.23 (-2.67%)
since 01/13/17

Most Recent Stories

More News
Detailed Research: Economic Perspectives on Fluidigm, Stemline Therapeutics, NeoGenomics, CVR Energy, W.R. Berkley, and Mack-Cali Realty -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fluidigm Corporation (NASDAQ:FLDM),...

CLI : 20.90 (+0.77%)
STML : 14.10 (+0.35%)
WRB : 69.48 (+0.06%)
CVI : 39.46 (+0.33%)
NEO : 8.35 (+0.60%)
FLDM : 6.77 (+2.73%)
Zacks.com highlights: Apache, PTC, NeoGenomics, Titan International and AMC Entertainment Holdings

Zacks.com highlights: Apache, PTC, NeoGenomics, Titan International and AMC Entertainment Holdings

APA : 47.31 (+0.32%)
AMC : 14.25 (-1.38%)
TWI : 14.22 (+1.94%)
NEO : 8.35 (+0.60%)
PTC : 66.03 (+0.15%)
Abandon These 5 Toxic Stocks or Sell Short for Profit

Pricey toxic stocks are susceptible to external shocks and are loaded with huge debt.

APA : 47.31 (+0.32%)
AMC : 14.25 (-1.38%)
TWI : 14.22 (+1.94%)
NEO : 8.35 (+0.60%)
PTC : 66.03 (+0.15%)
NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials

ROLLE, SWITZERLAND--(Marketwired - November 09, 2017) - NeoGenomics Inc. (NASDAQ: NEO), a leading global specialty oncology testing laboratory, opened the doors of its new Rolle, Switzerland facility...

NEO : 8.35 (+0.60%)
NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials

ROLLE, SWITZERLAND--(Marketwired - November 09, 2017) - NeoGenomics Inc. (NASDAQ: NEO), a leading global specialty oncology testing laboratory, opened the doors of its new Rolle, Switzerland facility...

NEO : 8.35 (+0.60%)
NeoGenomics, Inc. to Host Earnings Call

Work

NEO : 8.35 (+0.60%)
NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017

37% Increase in Pharma Services Revenue

NEO : 8.35 (+0.60%)
NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017

37% Increase in Pharma Services Revenue

NEO : 8.35 (+0.60%)
Investor Network Invites You to the NeoGenomics Third Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, October 25, 2017

FORT MYERS, FL / ACCESSWIRE / October 24, 2017 / NeoGenomics, Inc. (NASDAQ: NEO) will host a conference call and live webcast to discuss the results of the third quarter 2017, to be held Wednesday, October...

NEO : 8.35 (+0.60%)
NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials

FT. MYERS, FL--(Marketwired - October 24, 2017) - NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services in the United States, announced today that it has opened...

NEO : 8.35 (+0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

2nd Resistance Point 8.77
1st Resistance Point 8.53
Last Price 8.35
1st Support Level 8.08
2nd Support Level 7.87

See More

52-Week High 11.63
Fibonacci 61.8% 9.91
Fibonacci 50% 9.38
Fibonacci 38.2% 8.84
Last Price 8.35
52-Week Low 7.12

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.